Main Article Content
This work involves separating and studying the aminoacylase-1 (ACY1) of amniotic fluid from healthy pregnant, mainly one peak with higher activity has been isolated by DEAE-Cellulose ion exchange from the proteinous supernatant produced by deposition of proteins using ammonium sulfate (65%) after dialysis. The purification folds reaching to 19 folds also gave one protein peak when injected into the gel filtration column, a high ACY1 purity was obtained, with 38 folds of purification. It was found that the molecular weight of the isolated ACY1 was up to 46698 Dalton when using gel chromatography technique.The effect of ACY1 isolate was studied on rats with oxidative stress caused by lead acetate(LA) at 40 mg / kg body weight and compared with normal rats by measuring the selected biochemical parameters which included: Glutathione (GSH), malondialdehyde (MDA), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) through liver and kidney tissue examination. The results showed a significant increase in the levels of (MDA, AST, ALT) and a decrease in the level of GSH compared with the control group, Also it has been observed there that was a significant decrease in the levels of (MDA, AST, ALT) and high level of GSH when injecting the ACY1 isolate in a dose of 4 mg / kg of rat weight with LA at 40 mg/kg. The results of the tissue examination demonstrated high pathological changes in the liver tissue of rats treated with LA at 40 mg/kg of rat weight when compared with normal rats. The liver and kidney tissue improved when treated with isolate at 4 mg / kg rat weight and LA. These results demonstrate the role of ACY1 in protecting from oxidative stress then can reduce the severity of various diseases.
Studying the effect of ACY1 isolated on rats with oxidative stress caused by lead acetate at a dose of 40 mg / kg body weight and compared with normal rats by measuring the selected biochemical parameters which included: Glutathione (GSH), malondialdehyde (MDA), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) as well as through liver and kidney tissue examination. The results showed a significant increase in the levels of (MDA, AST, ALT) and a decrease in the level of GSH compared with the control group, It was also observed that there was a significant decrease in the levels (MDA, AST, ALT) and high level of GSH when using the enzyme isolated in a dose of 4 mg / kg of rat weight with lead acetate at a dose of 40 mg/kg. The results of the tissue examination showed high pathological changes in the liver tissue of rats treated with lead acetate at a dose of 40 mg/kg of rat weight when compared with normal rats, and liver and kidney tissue improvement when isolated enzyme is administered at 4 mg / kg rat weight with lead acetate. These results demonstrate the role of isolated enzyme in protecting the body from oxidative stress then can reducing the severity of various diseases.
Received 30/3/2020, Accepted 28/7/2020, Published Online First 21/2/2021
This work is licensed under a Creative Commons Attribution 4.0 International License.
Cheng Q, Gu S, Liu Z, Wang C, Li X. Expressional divergence of the fatty acid-amino acid conjugate hydrolyzing aminoacylase 1 (LACY-1) in Helicoverpa armigera and Helicoverpa assulta. Sci. Rep. 2017; 7: 8721.
Sommer A, Christensen E, Schwenger S. The molecular basis of aminoacylase 1 deficiency. Biochim. Biophys. Acta. 2011;1812:685–690.
Nelson D L, Cox M M. Lehninger principles of biochemistry- 7th Ed. W.H. Freeman and Co Ltd. New York. USA. 2017; pp. 68-146.
Yu B, Yu N, Liu X, Cao X, Zhang C, Chang H. Study of the expression and function of ACY1 in patients with colorectal cancer. Oncol. Lett. 2017;13: 2459-2464.
Maceyka M, Nava VE, Misltien S, Spiegel S . Aminoacylase 1 is a sphingosine kinase-1 interacting protein. FEBS Lett. 2004;568:30-34.
Sass JO, Vaithilingam J, Gemperle-Britschgi C, Delnooz CC, Kluijtmans LA, van de Warrenburg BP, et al. Expanding the phenotype in aminoacylase 1 (ACY1) deficiency: characterization of the molecular defect in a 63-year-old woman with generalized dystonia. Metab. Brain. Dis. 2016; 31(3):587-92.
Alessandrì G, Casarano M, Pezzini I, Doccini S, Nesti C. Isolated mild intellectual disability expands the aminoacylase 1 phenotype spectrum. JIMD Rep. 2014;16:18-78.
Rodríguez-Rodríguez P, Ramiro-Cortijo D, Reyes-Hernández G. Implication of oxidative stress in fetal programming of cardiovascular disease. Front. Physiol. 2018; 9:602.
Lumaka A, Race V, Peeters H, Corveleyn A, Coban-Akdemir Z, Jhangiani SN, et al . A comprehensive clinical and genetic study in 127 patients with ID in Kinshasa, DR Congo. Am. J. Med. Genet. 2018;176(9):1897-1909
Al-Helaly L A. Studies on paraoxonase-1 isolated from amniotic fluid and its effect against cisplatin-induced hepatotoxicity and cardiotoxicity in rats. Raf. J. Sci. 2018; 27(2):42-56.
Schacterle GR, Pollack RL. A simplified method for the quantitative assay of small amounts of protein in biological material. Anal. Biochem. 1973; 51: 654-55.
Peterson GL. Determination of total protein . Met. Enzymol. 1983;91:95-119.
Burtis C A, Ashwood E R, Bruns DE. Tietz textbook of clinical chemistry and molecular diagnostics. By Saunders, an imprint of Elsevier Inc. USA. 2012:pp.356, 368.
Robyt JF, White BJ. Biochemical techniques, Theory and practice. Wadsworth, Inc., Belmont, California, USA. 1987; p.40, 88.197.
Al-Helaly L A. Isolation of prolidase from amniotic fluid and study of its kinetic and affinity properties towards pharmacological compounds. EDUSJ. 2019; 28(3): 52-72.
Rodwell V W, Bender D A, Botham K M, Kennelly P J, Weil P A. Harper's illustrated biochemistry. 31st ed. The McGraw-Hill Companies. 2018;pp.251, 265.
Rosen H. A modified ninhydrin colorimetric analysis for amino acids . Arch. Biochem. Biophys. 1957;67:10-15.
Fauziah PN, Maskoen AM, Yuliati T, Widiarsih E. Optimized steps in determination of malondialdehyde (MDA) standards to diagnostic of lipid peroxidation. Padjadjaran J. Dent. 2018;30(2):136-139.
Luna LG. Manual of histological staining methods of armed forces institute of pathology. 3rd.ed., McGraw-Hill Book Company ,New York, Toronto, London and Sydney. 1968;pp3-8,
Smith T, Said Ghandour M, Wood PL. Detection of N-acetyl methionine in human and murine brain and neuronal and glial derived cell lines. J. Neurochem. 2011;118(2):187-194.
Zhong Y, Onuki J, Yamasaki T. Genome-wide analysis identifies a tumor suppressor role for aminoacylase 1 in iron-induced rat renal cell carcinoma. J. Carcinog. 2009; 30:158–164.
GiardinaT, Perrier J, Puigserver A. The rat kidney acylase I, characterization and molecular cloning differences with other acylases I. Euro. J. Bio. Chem. Banner. 2001; 267 (20):6249-6255.
El Tantawy Y. Antioxidant effects of Spirulina supplement against lead acetate-induced hepatic injury in rats. J. Tra. Comp. Med. 2016;6(4): 327-331.
Scinicariello F, Murray HE, Moffett DB, Abadin HG, Sexton MJ. Lead and deltaaminolevulinic acid dehydratase polymorphism: where does it lead? A meta-analysis. Environ. Health. Perspect. 2007;115(1):35-41.
Ansar S, Farhat S, Albati A, Abudawood M, Hamed S. Effect of curcumin and curcumin nanoparticles against lead induced nephrotoxicity. Biomed. Res. 2019;30 (1): 57-60
Rubino F. Toxicity of glutathione-binding metals: A review of targets and mechanism. Toxics. 2015;3(1):20–62.
Zou H, Sun J, Wu B, Yuan Y, Gu J, Bian J, et al. Effects of cadmium and/or lead on autophagy and liver injury in rats. Biol. Trace Elem. Res. 2020; doi: 10.1007/s12011-020-02045-7. [Epub ahead of print]
Dacaj R, Izetbegovic S, Dreshaj S. Elevated liver enzymes in cases of preeclampsia and intrauterine growth restriction. Med. Arch. 2016;70(1): 44–47.
Moneim AE. Indigofera oblongifolia prevents lead acetate-induced hepatotoxicity, oxidative stress, fibrosis and apoptosis in rats. PLoS One. 2016;11(7): e0158965.
Shatha HK, Nazarmuteb ZA, Moayad MU. The effect of penicillamine in reducing the toxic effects of lead acetate on some blood parameters, liver functions and testicular tissue in male rats. Int. J. Pharm. Res. 2016;5: 22-40.
Lamidi IY, Akefe IO. Mitigate effects of antioxidants in lead toxicity. Res. Rep. Toxi. 2017;1 (1):3.